» Articles » PMID: 9125764

Postinflammatory Hypopigmentation and Hyperpigmentation

Overview
Date 1997 Mar 1
PMID 9125764
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Postinflammatory hypopigmentation and hyperpigmentation are frequently encountered problems and represent the sequelae of various cutaneous disorders as well as therapeutic interventions. However, the underlying mechanisms and the variability individuals show for developing hypopigmentation or hyperpigmentation are not well understood. The authors propose an inherited individual chromatic tendency that is based on "weak" or "strong" melanocytes and their tendency to respond to trauma or inflammation with either hypopigmentation or hyperpigmentation. Clinical examples and management of both hypopigmentation and hyperpigmentation are discussed.

Citing Articles

Post-inflammatory hyperpigmentation after carbon dioxide laser: review of prevention and risk factors.

Dakhil A, Shadid A, Altalhab S Dermatol Reports. 2024; 15(4):9703.

PMID: 38205425 PMC: 10777097. DOI: 10.4081/dr.2023.9703.


Anti-Melanogenic Effects of Root Extract via Downregulation of PKA/CREB and MAPK/CREB Signaling Pathways in B16F10 Cells.

Park S, Han N, Lee J, Lee J, An S, Bae S Plants (Basel). 2023; 12(21).

PMID: 37960022 PMC: 10648933. DOI: 10.3390/plants12213666.


Post-Inflammatory Hypopigmentation: Review of the Etiology, Clinical Manifestations, and Treatment Options.

Rao M, Young K, Jackson-Cowan L, Kourosh A, Theodosakis N J Clin Med. 2023; 12(3).

PMID: 36769891 PMC: 9917556. DOI: 10.3390/jcm12031243.


Post-Inflammatory Hyperpigmentation in Dark Skin: Molecular Mechanism and Skincare Implications.

Markiewicz E, Karaman-Jurukovska N, Mammone T, Idowu O Clin Cosmet Investig Dermatol. 2022; 15:2555-2565.

PMID: 36466945 PMC: 9709857. DOI: 10.2147/CCID.S385162.


Assessment of stem cell factor expression and its c-KIT receptor in patients with vitiligo.

Wilamowska-Kokoszko D, Lukasik K, Szepietowski J, Skarzynski D, Owczarczyk-Saczonek A, Hlebowicz-Skrodzka J Postepy Dermatol Alergol. 2022; 39(4):762-767.

PMID: 36090724 PMC: 9454355. DOI: 10.5114/ada.2021.110266.